1. Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer: a subgroup analysis of the NAVIGATE ESUS randomized trial. (11th March 2020) Authors: Martinez‐Majander, N.; Ntaios, G.; Liu, Y. Y.; Ylikotila, P.; Joensuu, H.; Saarinen, J.; Perera, K. S.; Marti‐Fabregas, J.; Chamorro, A.; Rudilosso, S.; Prats‐Sanchez, L.; Berkowitz, S. D.; Mundl, H.; Themeles, E.; Tiainen, M.; Demchuk, A.; Kasner, S. E.; Hart, R. G; Tatlisumak, T. Journal: European journal of neurology Issue: Volume 27:Number 5(2020) Page Start: 841 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗